Balyasny Asset Management’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.21M | Sell |
53,859
-327,337
| -86% | -$33.6M | 0.01% | 1345 |
|
|
2025
Q4 | $40.5M | Buy |
+381,196
| New | +$44.2M | 0.05% | 415 |
|
|
2025
Q3 | – | Sell |
-99,900
| Closed | -$12.3M | – | 3031 |
|
|
2025
Q2 | $12.3M | Sell |
99,900
-88,046
| -47% | -$10.1M | 0.02% | 877 |
|
|
2025
Q1 | $19M | Buy |
187,946
+124,339
| +195% | +$12.1M | 0.03% | 617 |
|
|
2024
Q4 | $5.87M | Sell |
63,607
-85,402
| -57% | -$8.39M | 0.01% | 1195 |
|
|
2024
Q3 | $14.4M | Sell |
149,009
-140,090
| -48% | -$12.6M | 0.02% | 775 |
|
|
2024
Q2 | $24.8M | Buy |
289,099
+214,532
| +288% | +$18M | 0.04% | 528 |
|
|
2024
Q1 | $6.16M | Buy |
+74,567
| New | +$5.46M | 0.01% | 1135 |
|
|
2023
Q3 | – | Sell |
-151,399
| Closed | -$10.3M | – | 2366 |
|
|
2023
Q2 | $10.3M | Buy |
+151,399
| New | +$9.49M | 0.02% | 764 |
|
|
2023
Q1 | – | Sell |
-7,105
| Closed | -$414K | – | 2785 |
|
|
2022
Q4 | $425K | Buy |
+7,105
| New | +$386K | ﹤0.01% | 1896 |
|
|
2022
Q2 | – | Sell |
-308,121
| Closed | -$17.4M | – | 2856 |
|
|
2022
Q1 | $17.4M | Buy |
+308,121
| New | +$16.1M | 0.06% | 471 |
|
|
2021
Q4 | – | Sell |
-28,989
| Closed | -$1.73M | – | 2325 |
|
|
2021
Q3 | $1.73M | Sell |
28,989
-144,469
| -83% | -$9.09M | 0.01% | 1179 |
|
|
2021
Q2 | $10.8M | Sell |
173,458
-95,334
| -35% | -$6.35M | 0.05% | 495 |
|
|
2021
Q1 | $17.5M | Buy |
+268,792
| New | +$17.5M | 0.09% | 310 |
|
|
2020
Q4 | – | Sell |
-190,771
| Closed | -$9.86M | – | 1419 |
|
|
2020
Q3 | $9.86M | Buy |
+190,771
| New | +$9.79M | 0.07% | 387 |
|
|
2019
Q4 | – | Sell |
-19,740
| Closed | -$994K | – | 1239 |
|
|
2019
Q3 | $994K | Sell |
19,740
-292,183
| -94% | -$14.7M | 0.01% | 835 |
|
|
2019
Q2 | $15.7M | Buy |
311,923
+94,869
| +44% | +$4.6M | 0.1% | 277 |
|
|
2019
Q1 | $10.1M | Sell |
217,054
-234,873
| -52% | -$11.9M | 0.07% | 382 |
|
|
2018
Q4 | $22.2M | Buy |
451,927
+155,396
| +52% | +$8.84M | 0.16% | 183 |
|
|
2018
Q3 | $18.4M | Sell |
296,531
-289,717
| -49% | -$17.6M | 0.08% | 324 |
|
|
2018
Q2 | $31.6M | Sell |
586,248
-26,616
| -4% | -$1.33M | 0.14% | 191 |
|
|
2018
Q1 | $27.9M | Buy |
612,864
+79,694
| +15% | +$3.42M | 0.12% | 243 |
|
|
2017
Q4 | $21M | Sell |
533,170
-226,859
| -30% | -$8.63M | 0.07% | 387 |
|
|
2017
Q3 | $28M | Sell |
760,029
-17,188
| -2% | -$612K | 0.11% | 248 |
|
|
2017
Q2 | $29.9M | Buy |
777,217
+628,142
| +421% | +$23M | 0.12% | 223 |
|
|
2017
Q1 | $5.08M | Sell |
149,075
-717,188
| -83% | -$23.6M | 0.02% | 700 |
|
|
2016
Q4 | $28.4M | Buy |
866,263
+660,882
| +322% | +$21.4M | 0.15% | 185 |
|
|
2016
Q3 | $6.63M | Buy |
205,381
+106,631
| +108% | +$3.45M | 0.04% | 458 |
|
|
2016
Q2 | $3.05M | Buy |
+98,750
| New | +$3.09M | 0.02% | 611 |
|
|
2015
Q4 | – | Sell |
-657,024
| Closed | -$20.1M | – | 1286 |
|
|
2015
Q3 | $20.1M | Buy |
+657,024
| New | +$22.9M | 0.15% | 188 |
|
|
2015
Q2 | – | Sell |
-181,536
| Closed | -$6.41M | – | 1191 |
|
|
2015
Q1 | $6.41M | Buy |
+181,536
| New | +$6.21M | 0.05% | 432 |
|
Other funds holding EHC
VPM
VCM
Balyasny Asset Management's EHC Position: Q1 2026 in Review
Balyasny Asset Management reduced its Encompass Health (EHC) stake by 86% in Q1 2026, selling an estimated $33.6M and leaving 53,859 shares worth $5.21M. The position accounts for 0.01% of the portfolio, ranked #1345.
Balyasny Asset Management first reported a position in EHC in Q1 2015 and has held it in 31 quarters since. The position peaked at $40.5M in Q4 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.
- Balyasny Asset Management held 53,859 shares of Encompass Health worth $5.21M as of Q1 2026.
- Balyasny Asset Management sold 327,337 Encompass Health shares in Q1 2026, an estimated $33.6M.
- Encompass Health made up 0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1345 holding.
- Balyasny Asset Management first reported a position in Encompass Health in Q1 2015 and has held it in 31 quarters since.
- Balyasny Asset Management's Encompass Health position peaked at $40.5M in Q4 2025.
- 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.